EC Decision on animal tissue soon, but with concessions
This article was originally published in Clinica
The European Commission is optimistic that the long-awaited Decision on medical devices containing animal tissues will be adopted by the end of the year, possibly in October or November. But some concessions have had to be made which will impact devices containing collagen, gelatine and tallow.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.